REPL

REPL

USD

Replimune Group Inc. Common Stock

$8.970-0.220 (-2.394%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$9.190

Haut

$9.410

Bas

$8.910

Volume

2.35M

Fondamentaux de l'Entreprise

Capitalisation Boursière

700.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

5.54M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $2.68Actuel $8.970Haut $17

Actualités Connexes

Analyst Upgrades

BMO Capital Upgrades Replimune Group to Market Perform, Raises Price Target to $11

BMO Capital analyst Evan David Seigerman upgrades Replimune Group from Underperform to Market Perform and raises the price target from $2 to $11.

Voir plus
BMO Capital Upgrades Replimune Group to Market Perform, Raises Price Target to $11
Analyst Upgrades

HC Wainwright & Co. Upgrades Replimune Group to Buy, Announces $12 Price Target

HC Wainwright & Co. analyst Robert Burns upgrades Replimune Group from Neutral to Buy and announces $12 price target.

Voir plus
HC Wainwright & Co. Upgrades Replimune Group to Buy, Announces $12 Price Target